BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27302734)

  • 1. Forty-eight cases of leiomyosarcoma of bone in Japan: A multicenter study from the Japanese musculoskeletal oncology group.
    Mori T; Nakayama R; Endo M; Hiraga H; Tomita M; Fukase N; Kobayashi E; Kawai A; Ueda T; Morioka H
    J Surg Oncol; 2016 Sep; 114(4):495-500. PubMed ID: 27302734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and prognostic factors for a consecutive case series of 115 patients with somatic leiomyosarcoma.
    Abraham JA; Weaver MJ; Hornick JL; Zurakowski D; Ready JE
    J Bone Joint Surg Am; 2012 Apr; 94(8):736-44. PubMed ID: 22517390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinicopathological features and outcomes in patients with primary leiomyosarcoma of bone and soft tissue.
    Gusho CA; Blank AT; Gitelis S
    J Surg Oncol; 2021 Apr; 123(5):1274-1283. PubMed ID: 33524203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava.
    Cananzi FC; Mussi C; Bordoni MG; Marrari A; De Sanctis R; Colombo P; Quagliuolo V
    J Surg Oncol; 2016 Jul; 114(1):44-9. PubMed ID: 27062161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary leiomyosarcoma of the vagina: a clinical analysis of 9 cases].
    Li L; Zhang R; Wu LY; Bai P; Li SM; Li HJ; Li XG
    Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):747-50. PubMed ID: 23302732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
    Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
    Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoma of the prostate: a single institutional review.
    Janet NL; May AW; Akins RS
    Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary leiomyosarcoma of extragnathic bone: clinicopathologic features and reevaluation of prognosis.
    Adelani MA; Schultenover SJ; Holt GE; Cates JM
    Arch Pathol Lab Med; 2009 Sep; 133(9):1448-56. PubMed ID: 19722754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hepatic leiomyosarcoma in adults: analysis of prognostic factors.
    Chi M; Dudek AZ; Wind KP
    Onkologie; 2012; 35(4):210-4. PubMed ID: 22488093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
    Zhao J; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cardiac leiomyosarcoma: an analysis of clinical characteristics and outcome patterns.
    Wang JG; Cui L; Jiang T; Li YJ; Wei ZM
    Asian Cardiovasc Thorac Ann; 2015 Jun; 23(5):623-30. PubMed ID: 25740020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
    Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
    Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma.
    Wu TI; Chang TC; Hsueh S; Hsu KH; Chou HH; Huang HJ; Lai CH
    Gynecol Oncol; 2006 Jan; 100(1):166-72. PubMed ID: 16182349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and prognostic factors for Ewing-family tumors of the extremities.
    Biswas B; Rastogi S; Khan SA; Mohanti BK; Sharma DN; Sharma MC; Mridha AR; Bakhshi S
    J Bone Joint Surg Am; 2014 May; 96(10):841-9. PubMed ID: 24875025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leiomyosarcoma of the Inferior Vena Cava: A Case Series and Review of the Literature.
    Alkhalili E; Greenbaum A; Langsfeld M; Marek J; Rana MA; Glew R; Nir I
    Ann Vasc Surg; 2016 May; 33():245-51. PubMed ID: 26802297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary leiomyosarcoma of the inferior vena cava: a 2-institution analysis of outcomes.
    Mann GN; Mann LV; Levine EA; Shen P
    Surgery; 2012 Feb; 151(2):261-7. PubMed ID: 21176932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival.
    Burt BM; Ocejo S; Mery CM; Dasilva M; Bueno R; Sugarbaker DJ; Jaklitsch MT
    Ann Thorac Surg; 2011 Oct; 92(4):1202-7. PubMed ID: 21867989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.